Editor – We read with great interest the article by Sancho-Salda?a et al. 1 Firstly, we would like to congratulate the authors who have nicely described a case of Guillain–Barré syndrome (GBS) following a SARS-CoV-2 infection and was found to have a leptomeningeal enhancement in magnetic resonance imaging (MRI) of the spine. Although there is numerous reporting on the neurological involvement of SARS-CoV-2 infection that has been published in the literature, we believe it is still justified to report any extrapulmonary cases of SARS-CoV-2 infection, as we are still learning about the disease. We have written a comprehensive review of literature on all published scientific articles of SARSCoV-2 infection with neurological involvement and summarised the wide spectrum of presentation which can present with or without respiratory symptoms.2 However, this article is the first to report leptomeningeal enhancement in addition to the GBS, which warranted further investigation.
展开▼
